Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methods of CD34+ cell separation: comparative analysis.

F Beaujean1

  • 1E.T.S. du Sud-Est Francilien, Hôpital Henri Mondor, Creteil, France.

Transfusion Science
|May 7, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique.

The Journal of bone and joint surgery. American volume·2006
Same author

[The "forgotten ones of reperfusion" in acute myocardial infarction: lessons from the ESTIM Limousin registry].

Archives des maladies du coeur et des vaisseaux·2005
Same author

Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.

The Journal of bone and joint surgery. American volume·2005
Same author

Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study.

Annals of oncology : official journal of the European Society for Medical Oncology·2004
Same author

Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma.

Leukemia·2003
Same author

Treatment of severe fetomaternal alloimmune thrombocytopenia with compatible frozen-thawed platelet concentrates.

British journal of haematology·2002
Same journal

Discontinuous automated calcium supplementation during thrombocytapheresis with the haemonetics MCS+ version C.

Transfusion science·2002
Same journal

Is Brazil entering a new age?

Transfusion science·2001
Same journal

Is Brazil entering a new age?

Transfusion science·2001
Same journal

Post-transfusion thrombocytopenia in recipients with anti-HLA antibody.

Transfusion science·2000
Same journal

The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe(3+) values.

Transfusion science·2000
Same journal

A relationship between glucose metabolism and NO-mediated iron mobilization from cells.

Transfusion science·2000
See all related articles

This review covers CD34 antigen technologies for purifying hematopoietic stem cells. It details methods like cell sorting and immunomagnetic selection for cellular therapy applications.

Area of Science:

  • Biotechnology
  • Hematology
  • Immunology

Background:

  • Hematopoietic stem cell purification is crucial for cellular therapies.
  • Technologies targeting the CD34 antigen have advanced significantly over the past decade.

Purpose of the Study:

  • To review and compare various technologies for CD34+ hematopoietic stem cell purification.
  • To discuss the quantitative and qualitative aspects of different purification systems.
  • To highlight technical progress in the clinical application of these methods.

Main Methods:

  • Review of established and emerging purification techniques.
  • Detailed description of panning, high-speed activated cell sorting, immunomagnetic selection, and immunoadsorption column separation.
  • Analysis of quantitative and qualitative performance metrics for each method.

Related Experiment Videos

Main Results:

  • Multiple technologies exist for CD34+ cell purification, each with distinct advantages and limitations.
  • Positive selection of hematopoietic stem cells is a key component of modern cellular therapy.
  • Ongoing technical advancements are improving the efficiency and efficacy of clinical cell purification.

Conclusions:

  • The choice of purification technology depends on specific clinical requirements and desired outcomes.
  • Continued innovation in CD34-based purification is essential for advancing cellular therapies.
  • Understanding the performance of different systems is vital for successful clinical implementation.